Medical supply company Baxter International Inc said on Monday it had agreed to buy Sanofi’s Seprafilm unit, which makes specialist surgical products, for $350 million in cash. France’s Sanofi is conducting a broad strategy review under new chief executive Paul Hudson, who will give some initial pointers on which businesses he wants to focus on at an investor day on Dec. 10. Sanofi took on Seprafilm, which is used to help manage bleeding in abdominal and pelvis operations, in 2011 as part of its purchase of Genzyme. …read more
Source:: Yahoo Finance
